Receptors, Antigen, T-Cell
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Receptors, Antigen, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D011948
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D12.776.543.750.705.816.824 
						 | 
					
					
						| Concept/Terms | 
						
							Receptors, Antigen, T-Cell- Receptors, Antigen, T-Cell
 - T-Cell Antigen Receptor
 - Antigen Receptor, T-Cell
 - Receptor, T-Cell Antigen
 - T Cell Antigen Receptor
 - T-Cell Receptors
 - Receptors, T-Cell
 - T Cell Receptors
 - T-Cell Receptor
 - Receptor, T-Cell
 - T Cell Receptor
 - Receptors, T-Cell Antigen
 - Receptors, T Cell Antigen
 - T-Cell Antigen Receptors
 - Antigen Receptors, T-Cell
 - Antigen Receptors, T Cell
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, T-Cell".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, T-Cell".
				
					
						- Receptors, Antigen, T-Cell
 - Complementarity Determining Regions
 - Receptor-CD3 Complex, Antigen, T-Cell
 - Receptors, Antigen, T-Cell, alpha-beta
 - Receptors, Antigen, T-Cell, gamma-delta
 
					
				 
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Receptors, Antigen, T-Cell" by people in this website by year, and whether "Receptors, Antigen, T-Cell" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 0 | 2 | 2 | 
| 1997 | 1 | 2 | 3 | 
| 1999 | 1 | 1 | 2 | 
| 2001 | 0 | 2 | 2 | 
| 2002 | 0 | 1 | 1 | 
| 2003 | 0 | 1 | 1 | 
| 2004 | 0 | 1 | 1 | 
| 2005 | 1 | 2 | 3 | 
| 2006 | 1 | 1 | 2 | 
| 2007 | 1 | 2 | 3 | 
| 2008 | 1 | 1 | 2 | 
| 2009 | 3 | 0 | 3 | 
| 2010 | 1 | 1 | 2 | 
| 2011 | 2 | 1 | 3 | 
| 2013 | 2 | 1 | 3 | 
| 2014 | 2 | 0 | 2 | 
| 2015 | 0 | 2 | 2 | 
| 2016 | 0 | 3 | 3 | 
| 2017 | 0 | 1 | 1 | 
| 2019 | 0 | 1 | 1 | 
| 2020 | 0 | 1 | 1 | 
| 2021 | 0 | 2 | 2 | 
| 2022 | 0 | 2 | 2 | 
| 2023 | 0 | 1 | 1 | 
| 2024 | 0 | 1 | 1 | 
| 2025 | 1 | 1 | 2 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Receptors, Antigen, T-Cell" by people in Profiles.
						
					
								- 
								
Disease diagnostics using machine learning of B cell and T cell receptor sequences. Science. 2025 Feb 21; 387(6736):eadp2407.
															
								 
							
								- 
								
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
															
								 
							
								- 
								
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee. Lancet Oncol. 2024 Aug; 25(8):e374-e387.
															
								 
							
								- 
								
TScan-II: A genome-scale platform for the de novo identification of CD4+ T?cell epitopes. Cell. 2023 Dec 07; 186(25):5569-5586.e21.
															
								 
							
								- 
								
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplant. 2022 06; 57(6):1025-1027.
															
								 
							
								- 
								
Development of aß T Cells with Innate Functions. Adv Exp Med Biol. 2022; 1365:149-160.
															
								 
							
								- 
								
Beyond CD19 CAR-T cells in lymphoma. Curr Opin Immunol. 2022 02; 74:46-52.
															
								 
							
								- 
								
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell. 2021 11 08; 39(11):1497-1518.e11.
															
								 
							
								- 
								
Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies. Curr Hematol Malig Rep. 2021 02; 16(1):32-39.
															
								 
							
								- 
								
Single Cell Transcriptomics Implicate Novel Monocyte and T Cell Immune Dysregulation in Sarcoidosis. Front Immunol. 2020; 11:567342.